Company profile
Jade Biosciences, Inc.
NASDAQ:JBIOBiotechnology: Pharmaceutical Preparations
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07059312 | phase1 | active_not_recruiting | 2025-08-17 | 2026-10-01 | Jade Biosciences, Inc. | A Phase 1 Study of JADE101 in Healthy Participants |
| NCT07533955 | phase1 | recruiting | 2026-05-19 | 2027-10-01 | Jade Biosciences, Inc. | A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis |
| NCT07525947 | phase1 | recruiting | 2026-05-01 | 2027-05-01 | Jade Biosciences, Inc. | A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants |
| NCT07541287 | phase2 | recruiting | 2026-05-19 | 2029-01-01 | Jade Biosciences, Inc. | A Study of JADE101 in Participants With Immunoglobulin A Nephropathy |
FDA applications (0)
No records yet.